As of August 31, 2014, Matthew W. Colman, M.D. and Adam B. Yanke, M.D. have joined the team of Midwest Orthopaedics at Rush (MOR) in Chicago. Dr. Colman is a graduate of University of Chicago Pritzker School of Medicine, and Adam B. Yanke, M.D. is a graduate of Rush Medical College.
Matthew Colman, M.D., Adam B. Yanke, M.D. Join “Rush”
1 min read Premium comments
Dr. Colman, who handles patients with sports-related, orthopedic conditions, completed one in Musculoskeletal Oncology at Harvard University and one in Orthopedic and Neurosurgical Spine Surgery at the University of Utah. A graduate of the Orthopedic Surgery residency program at Pittsburgh, Dr. Colman specializes in bone and soft tissue tumors.
Dr. Yanke did his fellowship in Orthopedic Sports Medicine at Rush University Medical Center and holds a special interest in advanced arthroscopy, shoulder replacement (with a special focus on patellofemoral dysfunction) and cartilage restoration.
Dr. Yanke told OTW, “I am very excited to get started at Midwest Orthopaedics at Rush. After training here for nearly 12 years, I’m happy to finally grow roots and start a practice here in Chicago.”
Dr. Colman told OTW, “My practice combines two disciplines: spine surgery and musculoskeletal oncology, enabling me to provide cutting edge, comprehensive care for patients with spine, tumor or spinal tumor conditions. In addition, I focus on clinical research and education related to these fields. Beginning a practice of this type would not be possible without the incredible work of the support staff and world-class physician partner network at Midwest Orthopaedics at Rush and Rush University Medical Center.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.